Fundamentals of cancer metabolism
Open accessThe DOI matches its Crossref record; 203 of the 204 references it cites were found in a registry or an index.
Abstract
Tumors reprogram pathways of nutrient acquisition and metabolism to meet the bioenergetic, biosynthetic, and redox demands of malignant cells. These reprogrammed activities are now recognized as hallmarks of cancer, and recent work has uncovered remarkable flexibility in the specific pathways activated by tumor cells to support these key functions. In this perspective, we provide a conceptual framework to understand how and why metabolic reprogramming occurs in tumor cells, and the mechanisms linking altered metabolism to tumorigenesis and metastasis. Understanding these concepts will progressively support the development of new strategies to treat human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IDH1/2 mutations have been identified in a range of tumor types, including solid tumors (e.g., gliomas and chondrosarcomas) and blood cancers like acute myelogenous leukemia (169, 170, 171).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [169]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we propose that pharmacological ascorbate can potentially circumvent this problem by exploring two common features of cancer cells: their increased levels of labile transition metals, especially iron21, and their increased reliance on glucose uptake and glycolysis22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Alternatively, certain cancer cells may use carbon sources such as glutamine or acetate to compensate for the reduction in acetyl-CoA synthesis from glucose [94,95].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [95]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Increased aerobic glycolysis is frequently observed in BAP1+/− cells [141], also analyzing the plasmatic metabolic profiles of individuals carrying different germline BAP1 mutations in comparison to BAP1 wild-type (BAP1WT) controls derived from two families [140].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [141]
Experimental — accuracy not yet measuredIn the citing paper
“Tumour cells exhibit a high rate of glycolysis, even in conditions with ample oxygen — a phenomenon that was first described by Otto Warburg, nearly a century ago22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 21×
“When tumor cells become nutrient-deprived, they adapt to the microenvironment by decreasing their demand for ATP.”
BackgroundInfluentialmTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 2×
“mTORC1 is stimulated by the presence of amino acids and activates protein synthesis via its effects on translation and ribosome biogenesis (80).”
BackgroundHow mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 1×
“ROS are intracellular chemical species that contain oxygen and include the superoxide anion (O2 ), hydrogen peroxide (H2O2), and the hydroxyl radical (OH·) (114).”
BackgroundThe emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“Because some altered metabolic features are observed quite generally across many types of cancer cells, reprogrammed metabolism is considered a hallmark of cancer (1, 2).”
BackgroundIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · cited 1×
“Themetabolic adaptation to hypoxia is coordinated by HIF-1, which induces metabolic genes involved in increasing glycolytic flux (23).”
Background
Cited by
Items 901–1,000 of 1,007
Yada, R. C., Desa, D. E., Gillette, A. A., Bartels, E., Harari, P. M., Skala, M. C., Beebe, D. J., & Kerr, S. C. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122136 · Cited by 30
Boolean dynamic modeling of cancer signaling networks: Prognosis, progression, and therapeutics
Sherekar, S., & Viswanathan, G. A. (2021) · Computational and Systems Oncology · doi:10.1002/cso2.1017 · Cited by 36
New insights into lipid metabolism and prostate cancer (Review)
Zhang, Z., Wang, W., Kong, P., Feng, K., Liu, C., Sun, T., Sang, Y., Duan, X., Tao, Z., & Liu, W. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5522 · Cited by 40
“The altered metabolic activity of fatty acids can contribute to the malignant properties of cancer cells (17).”
BackgroundFarsani, S. S. M., & Verma, V. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1175532 · Cited by 36
“Hence, anabolism and catabolism represent two opposite ends of the metabolic spectrum (9).”
BackgroundIntratumoral metabolic heterogeneity of colorectal cancer
Hirose, Y., & Taniguchi, K. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2021 · Cited by 33
Luo, H., Wang, Q., Yang, F., Liu, R. R., Gao, Q., Cheng, B., Lin, X., Huang, L., Chen, C., Jin, X., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.164968 · Cited by 220
“As suggested in a recent review (39), the term “oncometabolites” refers to a class of small molecular compounds that are significantly increased in tumors and have defined mechanisms through which they participate in the process of malignant progression.”
Campos, M., & Albrecht, L. V. (2023) · Cancers · doi:10.3390/cancers16010016 · Cited by 36
“Intermediates throughout the pathway also generate precursors for serine (one carbon metabolism), sugars (protein glycosylation), and nucleotide synthesis (pentose phosphate pathway) [1].”
BackgroundBeyond cell cycle regulation: The pleiotropic function of CDK4 in cancer
Ziegler, D. V., Parashar, K., & Fajas, L. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.002 · Cited by 35
“In contrast, in many cancer cells, even in the presence of oxygen, pyruvate is converted into lactate in the so-called Warburg effect [28].”
BackgroundMeng, Q., Xie, Y., Sun, K., He, L., Wu, H., Zhang, Q., & Liang, T. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01862-2 · Cited by 34
“This study was approved by the Institutional Review Board at the First Af fi liated Hospital, School of Medicine, Zhejiang University.”
Duan, N., Hua, Y., Yan, X., He, Y., Zeng, T., Gong, J., Fu, Z., Li, W., & Yin, Y. (2024) · Advanced Science · doi:10.1002/advs.202309424 · Cited by 38
Pioneering noninvasive colorectal cancer detection with an AI-enhanced breath volatilomics platform
Liu, Y., Ji, Y., Chen, J., Zhang, Y., Chen, Y., Li, X., & Li, X. (2024) · Theranostics · doi:10.7150/thno.94950 · Cited by 31
“Interestingly, a study by DeBerardinis et al. has found that the lipid membrane of cancerous cells exhibits a pronounced saturation compared to their benign counterparts [33].”
BackgroundPeroxisomes and PPARs: Emerging role as master regulators of cancer metabolism
Pratama, A. M., Sharma, M., Naidu, S., Bömmel, H. M., Prabhuswamimath, S. C., Madhusudhan, T., Wihadmadyatami, H., Bachhuka, A., & Karnati, S. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102044 · Cited by 36
Metabolic Plasticity of Stem Cells and Macrophages in Cancer
Krstić, J., Trivanović, D. I., Jauković, A., Santibanez, J. F., & Bugarski, D. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00939 · Cited by 31
“Bio chim Biophys Acta (2012) 1820(5):571–6.”
BackgroundInfluentialRetracted: Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity
Ohba, S., Johannessen, T.-C. A., Chatla, K., Yang, X., Pieper, R. O., & Mukherjee, J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.082 · Cited by 30
RetractedAbrogating GPT2 in triple‐negative breast cancer inhibits tumor growth and promotes autophagy
Mitra, D., Vega-Rubín-de-Celis, S., Royla, N., Bernhardt, S., Wilhelm, H., Tarade, N., Poschet, G., Buettner, M., Binenbaum, I., Borgoni, S., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33456 · Cited by 33
“Metabolic reprogramming is an essential part of tumorigenesis, which is prominently characterized by the Warburg effect and glutamine anaplerosis.(2,3,36) Glutamine-dependent growth is an important feature of several aggressive cancers including the TNBC subtype.”
BackgroundAmrutkar, M., & Gladhaug, I. P. (2021) · Cancers · doi:10.3390/cancers13040601 · Cited by 33
“Cancer metabolism, the oldest area of research in cancer biology, is based on the principle that metabolic activities are significantly altered in tumor cells compared to normal cells [25,26].”
BackgroundInfluentialMetabolic Alterations and Therapeutic Opportunities in Rare Forms of Melanoma
Han, A., Schug, Z. T., & Aplin, A. E. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.05.005 · Cited by 36
Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro
Tan, M. L., Lu, L., & Fischbach, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113852 · Cited by 32
The Interplay between Cell-Extracellular Matrix Interaction and Mitochondria Dynamics in Cancer
Yanes, B., & Rainero, E. (2022) · Cancers · doi:10.3390/cancers14061433 · Cited by 32
“In addition, low levels of ROS can regulate metabolic pathways and cell proliferation [2,28].”
BackgroundSuppression of Energy Metabolism in Cancer Cells with Nutrient-Sensing Nanodrugs
Zhang, J., Yin, Y., Zhang, J., Zhang, J., Su, W., Ma, H., Jia, F., Zhao, G., & Wang, H. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c00356 · Cited by 31
Liu, C., Wu, Z., Wang, L., Yang, Q., Huang, J., & Huang, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012123 · Cited by 31
“Moreover, mutation or loss of p53 leads to an increase in the Warburg effect and intracellular oxidative stress, thereby promoting migration and metastasis of cancer cells [24,46,47].”
BackgroundEicosanoids in prostate cancer
Panagiotopoulos, A. A., Kalyvianaki, K., Castanas, E., & Kampa, M. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9750-0 · Cited by 32
Yoshida, T., Yokobori, T., Saito, H., Kuriyama, K., Kumakura, Y., Honjo, H., Hara, K., Sakai, M., Miyazaki, T., Obinata, H., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08711-3 · Cited by 30
Isotope tracing in health and disease
Dong, W., Rawat, E. S., Stephanopoulos, G. N., & Abu-Remaileh, M. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102739 · Cited by 31
Zhou, X., Li, Y., Yang, C., Chen, D., Wang, T., Liu, T., Yan, W., Su, Z., Peng, B., & Ren, X. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121698 · Cited by 32
Mondal, S., Sthanikam, Y., Kumar, A., Nandy, A., Chattopadhyay, S., Koner, D., Rukmangadha, N., Hulikal, N., & Banerjee, S. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c01019 · Cited by 31
Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma
Wang, Z., Li, Q., & Liang, B. (2024) · Pharmaceuticals · doi:10.3390/ph17081057 · Cited by 36
“This metabolic adaptation supports the energy needs of hypoxic cancer cells, sustaining their growth and survival [34].”
BackgroundLin, J., Lee, J. H. J., Paramasivam, K., Pathak, E., Wang, Z., Pramono, Z. A. D., Lim, B., Wee, K. B., & Surana, U. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.10.001 · Cited by 31
Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer
Han, Y., Cho, U., Kim, S., Park, I. S., Cho, J., Dhanasekaran, D. N., & Song, Y. S. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1459594 · Cited by 33
“cancer cells exhibit increased glycolysis under aerobic condition [6].”
BackgroundMetabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know?
Galicia-Vázquez, G., & Aloyz, R. S. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.12.003 · Cited by 32
Obeidat, Y., Cheng, M.-H., Catandi, G. D., Carnevale, E. M., Chicco, A. J., & Chen, T. W. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.02.069 · Cited by 32
microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance
Zhang, W. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236094 · Cited by 30
“Cancer cells depend on both glycolysis and glucose oxidation to support their growth [162,163] as well as glutaminolysis that catabolizes glutamine to generate ATP and lactate [164].”
BackgroundZhao, M., Liu, Y., Chang, J., Jin, Q., Liu, R., Hou, Y., Wang, Y., Zhang, X., Qiao, L., & Ren, L. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0050 · Cited by 31
Rizza, S., Leo, L. D., Mandatori, S., Zio, D. D., & Filomeni, G. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113885 · Cited by 31
Progress of Iron-Based Nanozymes for Antitumor Therapy
Sutrisno, L., Hu, Y., Hou, Y., Cai, K., Li, M., & Luo, Z. Y. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00680 · Cited by 29
“Enzymes are a class of powerful catalysts that are responsible for accelerating various chemical reactions in the human body and are required to promote numerous biological processes, such as metabolism, detoxification, and biosynthesis (DeBerardinis and Chandel, 2016; Huang et al., 2019; Leveson-Gower et al., 2019; W…”
BackgroundSun, H.-W., Chen, J., Wu, W., Yang, Y., Xu, Y.-T., Yu, X.-J., Chen, H., Wang, Z., Wu, X., & Zheng, L. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0389 · Cited by 30
“Intensive studies have reported that the reprogrammedmetabolism seen in cancer is characterized by enhanced aerobic glycolysis and glutaminolysis, which can fulfill the bioenergetic and biosynthetic demands of cancer cells (2, 46, 47).”
BackgroundLiu, R., & Godbout, R. (2020) · Cancers · doi:10.3390/cancers12123823 · Cited by 35
“Metastatic cancer cells have unique metabolic demands, requiring high levels of energy for migration, dissemination and invasion, along with the need to adapt to new environments at metastatic sites that may not be as favorable as the primary site [55].”
BackgroundDietary intake of branched‐chain amino acids and survival after colorectal cancer diagnosis
Long, L., Yang, W., Liu, L., Tobias, D. K., Katagiri, R., Wu, K., Jin, L., Zhang, F., Luo, X., Liu, X., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33449 · Cited by 31
“BCAAs, as essential nutrients for cancer growth, are utilized by tumor in various biosynthetic pathways and as an energy source of tumor cells.(32) In particular, tumor cells distant from the vasculature have diminished accessibility to nutrients and oxygen and may engage in alternative forms of metabolism including o…”
BackgroundChang, J., Go, S., Gilglioni, E. H., Duijst, S., Panneman, D. M., Rodenburg, R. J., Li, H. L., Huang, H.-L., Levin, L. R., Buck, J., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2020.148367 · Cited by 31
Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer
Balihodzic, A., Barth, D. A., Prinz, F., & Pichler, M. (2021) · Cancers · doi:10.3390/cancers13050977 · Cited by 29
“To satisfy the accompanying increased demand for energy, cancer cells have to reprogram their metabolism, especially glucose metabolism [1,2].”
BackgroundSrivatsav, A. T., & Kapoor, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.640355 · Cited by 36
Natural Compounds as Metabolic Modulators of the Tumor Microenvironment
Dias, A. S., Helguero, L. A., Almeida, C. R., & Duarte, I. F. (2021) · Molecules · doi:10.3390/molecules26123494 · Cited by 34
“Their detailed description can be found in excellent recent reviews [17,18].”
BackgroundCell cycle induction in human cardiomyocytes is dependent on biosynthetic pathway activation
Abouleisa, R., McNally, L. A., Salama, A. B. M., Hammad, S. K., Ou, Q., Wells, C., Lorkiewicz, P., Bolli, R., Mohamed, T., & Hill, B. G. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102094 · Cited by 29
“acids, lactate, serine, and glycine, also provide material resources required for replication [19,20].”
Macias, L. A., Garza, K. Y., Feider, C. L., Eberlin, L. S., & Brodbelt, J. S. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c05295 · Cited by 29
Krysztofiak, A., Szymonowicz, K., Hlouschek, J., Xiang, K., Waterkamp, C., Larafa, S., Goetting, I., Vega-Rubín-de-Celis, S., Theiß, C., Matschke, V., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103366 · Cited by 33
“Altered cellular metabolism is an important feature of nearly all types of cancer and represents the key driving force for cancer growth and malignant progression (DeBerardinis and Chandel, 2016; Faubert et al., 2020; Hanahan and Weinberg, 2011).”
BackgroundHistone N-terminal acetyltransferase NAA40 links one-carbon metabolism to chemoresistance
Demetriadou, C., Raoukka, A., Charidemou, E., Mylonas, C., Michael, C., Parekh, S., Koufaris, C., Skourides, P. A., Papageorgis, P., Tessarz, P., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02113-9 · Cited by 30
“In order for tumour cells to acquire and maintain unabated cell proliferation and chemoresistance they need to rewire their metabolic program favoring core functions like nucleotide biosynthesis and energy production [8].”
BackgroundRavera, S., Bertola, N., Pasquale, C., Bruno, S., Benedicenti, S., Ferrando, S., Zekiy, A. O., Arany, P. R., & Amaroli, A. (2021) · Biomedicines · doi:10.3390/biomedicines9111717 · Cited by 32
“Recently, the role of aerobic glycolysis supported by oncogenes was confirmed, but studies have also demonstrated that the tumor cells prevalently produce energy through glucose oxidation and oxidative phosphorylation, which takes place in mitochondria [52,54].”
BackgroundInfluentialAdvances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review)
Chen, N., Zhou, Y.-S., Wang, L.-C., & Huang, J. (2022) · Oncology Reports · doi:10.3892/or.2022.8266 · Cited by 29
Wang, D., Wang, F., Kong, X., Li, Q., Shi, H., Zhao, S., Li, W., Li, Y., & Meng, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113376 · Cited by 33
Nanomedicines Targeting Metabolism in the Tumor Microenvironment
Ren, M., Zheng, X., Gao, H., Jiang, A., Yao, Y., & He, W. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.943906 · Cited by 35
“To meet the demands of unrestrained proliferation, cancer cells undergo specialized alterations in various metabolic pathways (DeBerardinis and Chandel, 2016).”
BackgroundSLC1A3 facilitates Newcastle disease virus replication by regulating glutamine catabolism
Liu, P., Tang, N., Meng, C., Yin, Y., Qiu, X., Tan, L., Sun, Y., Song, C., Liu, W., Liao, Y., et al. (2022) · Virulence · doi:10.1080/21505594.2022.2112821 · Cited by 30
Indini, A., Fiorilla, I., Ponzone, L., Calautti, E., & Audrito, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179985 · Cited by 33
Combined inhibition of ACLY and CDK4/6 reduces cancer cell growth and invasion
Velez, B. C., Petrella, C., DiSalvo, K. H., Cheng, K., Kravtsov, R. L., Krasniqi, D., & Krucher, N. A. (2022) · Oncology Reports · doi:10.3892/or.2022.8469 · Cited by 36
“Several oncogenes have been implicated in stimulating glycolysis in tumor cells (29,31).”
Quercetin-Induced Glutathione Depletion Sensitizes Colorectal Cancer Cells to Oxaliplatin
Lee, J., Jang, C. H., Kim, Y., Oh, J., & Kim, J. (2023) · Foods · doi:10.3390/foods12081733 · Cited by 33
“Nonetheless, the majority of cancer cells exhibit elevated levels of ROS due to an augmented metabolic rate, genetic mutation, and a state of relative hypoxia [53,54], which is attributed as a cause of metabolic reprogramming [55,56].”
BackgroundCholesterol efflux pathways hinder KRAS-driven lung tumor progenitor cell expansion
Guilbaud, E., Barouillet, T., Ilié, M., Borowczyk, C., Ivanov, S., Sarrazy, V., Vaillant, N., Ayrault, M., Castiglione, A., Rignol, G., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.05.005 · Cited by 30
Metabolomics in aging research: aging markers from organs
Fang, W., Chen, S., Jin, X., Liu, S., Cao, X., & Liu, B. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1198794 · Cited by 33
Friend or Foe? Mitochondria as a Pharmacological Target in Cancer Treatment
Dickerson, T., Jauregui, C. E., & Teng, Y. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0110 · Cited by 28
Lagziel, S., Lee, W. D., & Shlomi, T. (2019) · BMC Biology · doi:10.1186/s12915-019-0669-x · Cited by 33
Schoonjans, C. A., Joudiou, N., Brusa, D., Corbet, C., Féron, O., & Gallez, B. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.003 · Cited by 28
Ketone bodies in cell physiology and cancer
Giuliani, G., & Longo, V. D. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00441.2023 · Cited by 33
Huang, T., Cao, H., Liu, C., Sun, X., Dai, S., Liu, L.-Z., Wang, Y., Guo, C., Wang, X., Gao, Y., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06775-7 · Cited by 30
“9).”
Zhen, X., Zhang, M., Hao, S., & Sun, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116935 · Cited by 32
Cancer metastasis: molecular mechanisms and therapeutic interventions
Dai, X., Xi, M., & Li, J. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00261-y · Cited by 31
“2 (See legend on previous page.) colonization [48], the process of which is dynamic and heterogeneous [49–51].”
Targeting mitochondrial transporters and metabolic reprogramming for disease treatment
Anselme, M., He, H., Lai, C., Luo, W., & Zhong, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06976-4 · Cited by 37
Metabolomics and metabolites in cancer diagnosis and treatment
Cai, M., Liu, H., Shao, C., Li, T., Jin, J., Liang, Y., Wang, J., Cao, J., Yang, B. K., He, Q., et al. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00362-8 · Cited by 34
“It also supports the biosynthesis of nucleotides and lipids [216].”
Aggarwal, S., Gabrovsek, L., Langeberg, L. K., Golkowski, M. G., Ong, S., Smith, F. D., & Scott, J. D. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006741 · Cited by 30
“Although changes in the phosphorylation status of Drp1 have been observed in neurons, this AKAP-mediated event may also be pertinent to the core of breast cancer tumors where nutrient deprivation is linked to elongated mitochondrial networks (25, 56, 61).”
BackgroundThe PGC-1/ERR network and its role in precision oncology
Vitto, H. D., Bode, A. M., & Dong, Z. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0081-6 · Cited by 33
“The most important metabolic plasticity mechanisms in cancer rely on glycolysis-dependent or mitochondrial OxPhos-addiction activities.(109,110) Both are considered metabolic hallmarks of cancer cells because they are involved in the direct activation of many oncogenic pathways.”
BackgroundPastore, M., Lori, G., Gentilini, A., Taddei, M. L., Maira, G. D., Campani, C., Recalcati, S., Invernizzi, P., Marra, F., & Raggi, C. (2020) · Cells · doi:10.3390/cells9030596 · Cited by 28
“The rewiring of cancer cells metabolism includes abnormalities in glucose homeostasis and other nutrients such as aminoacid and lipid and impairment of mitochondrial function [22].”
BackgroundInfluentialBatsios, G., Najac, C., Cao, P., Viswanath, P., Subramani, E., Saito, Y., Gillespie, A. M., Yoshihara, H. A. I., Larson, P. E. Z., Sando, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63160-y · Cited by 28
Neural signaling modulates metabolism of gastric cancer
Rabben, H.-L., Andersen, G. T., Olsen, M. K., Øverby, A., Ianevski, A., Kainov, D. E., Wang, T. C., Lundgren, S., Grønbech, J. E., Chen, D., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102091 · Cited by 32
Harris, B., Zhang, Y., Tao, J., Shen, R., Zhao, X., Cleary, M. P., Wang, T., & Yang, D. (2021) · The FASEB Journal · doi:10.1096/fj.202001415rr · Cited by 37
The ER-mitochondria Ca2+ signaling in cancer progression: Fueling the monster
Bustos, G., Ahumada-Castro, U., Silva-Pavez, E., Puebla, A., Lovy, A., & Cárdenas, C. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.03.006 · Cited by 28
STARD3: A Prospective Target for Cancer Therapy
Asif, K., Memeo, L., Palazzolo, S., Frión-Herrera, Y., Parisi, S., Caligiuri, I., Canzonieri, V., Granchi, C., Tuccinardi, T., & Rizzolio, F. (2021) · Cancers · doi:10.3390/cancers13184693 · Cited by 37
“Cancer cells require high amounts of nucleic acids, proteins, and lipids for their survival [79].”
BackgroundMyoglobin: From physiological roles to potential implications in cancer
Elkholi, I. E., Elsherbiny, M. E., & Emara, M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188706 · Cited by 34
Guo, L., Zhang, W., Xie, Y., Chen, X., Olmstead, E. E., Lian, M., Zhang, B., Zaytseva, Y. Y., Evers, B. M., Spielmann, H. P., et al. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0925 · Cited by 33
Tong, Q., Qin, W. D., Li, Z., Liu, C., Wang, Z., Chu, Y., & Xu, X. (2023) · Cancer Medicine · doi:10.1002/cam4.5605 · Cited by 27
Liu, X., Qin, H., Zhang, L., Jia, C., Chao, Z., Qin, X., Zhang, H., & Chen, C. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102647 · Cited by 33
“Cancer-associated metabolic alteration is a hallmark of malignant tumors, including lung cancer [30].”
BackgroundPandey, A., & Trigun, S. K. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30447 · Cited by 31
“During recent past, modulation of certain key hot spots of the tumour growth‐supportive biochemical process derived much scientific interest.(3,4) The growing tumour cells are found to exploit autophagy mechanism for deriving their survival benefits(5) and hence, modulating tumour cell autophagy could be a novel but r…”
BackgroundPalma, F. R., Coelho, D. R., Pulakanti, K., Sakiyama, M. J., Huang, Y., Ogata, F. T., Danes, J. M., Meyer, A. E., Furdui, C. M., Spitz, D. R., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113897 · Cited by 31
“5,26 In 2020, Desai et al. 38 showed that mitochondria and the nucleus are directly connected and communicate, at least in part, via the transfer of mitochondria-derived ROS.”
BackgroundH. Dovmark, T., Hulikova, A., A. Niederer, S., D. Vaughan‐Jones, R., & Swietach, P. (2018) · The FASEB Journal · doi:10.1096/fj.201700480r · Cited by 28
“Finite energetic resources force cancer cells to rationalize energy utilization (39), either by austerity, such as by inactivating certain biologic functions of the precursor”
BackgroundThe role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy
Ganjoo, S., Gupta, P., Corbali, H. I., Nanez, S., Riad, T. S., Duong, L. K., Barsoumian, H. B., Masrorpour, F., Jiang, H., Welsh, J. W., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1172931 · Cited by 35
Luo, K., Qian, Z., Jiang, Y., Lv, D., Zhu, K., Shao, J., Hu, Y. C., Lv, C., Huang, Q., Gao, Y., et al. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107078 · Cited by 31
Li, M., Wu, X., Jing, W.-Q., Hou, W.-K., Hu, S. C., & Yan, W. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06017-2 · Cited by 31
Jablonowski, C. M., Quarni, W., Singh, S. V., Tan, H., Bostanthirige, D. H., Jin, H., Fang, J., Chang, T., Finkelstein, D., Cho, J., et al. (2024) · eLife · doi:10.7554/elife.90993 · Cited by 45
“Metabolic reprogramming is a hallmark of cancer ( Hanahan and Weinberg, 2011 ; Pavlova and Thompson, 2016 ; Vazquez et al., 2016 ), which allows rapidly proliferating tumor cells to acquire nutrients to meet their bioenergetic, biosynthetic, and redox demands ( DeBerardinis and Chandel, 2016 ).”
BackgroundTian, J., Luo, J., Zeng, X., Ke, C., Wang, Y., Liu, Z., Li, L., Zhang, Y., Hu, Z., & Yang, C. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008226 · Cited by 32
Mitochondria regulate proliferation in adult cardiac myocytes
Waypa, G. B., Smith, K. A., Mungai, P. T., Dudley, V. J., Helmin, K. A., Singer, B. D., Peek, C. B., Bass, J. T., Nelson, L., Shah, S. J., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci165482 · Cited by 33
Self-citationNguyen, T. N. H., Horowitz, L. F., Krilov, T., Lockhart, E. J., Kenerson, H. L., Gujral, T. S., Yeung, R. S. W., Arroyo‐Currás, N., & Folch, A. (2024) · Science Advances · doi:10.1126/sciadv.adn5875 · Cited by 28
“…cellular diversity of the human tumor microenvironment (TME) ( 15 ), namely heterogeneous distributions of extracellular matrix scaffolds ( 16 ), immune cells ( 17 , 18 ), vasculature, and metabolic gradients ( 17 – 19 ) that can each affect the tumor’s response or resistance to cancer therapies.”
BackgroundThe role of short-chain fatty acids in cancer prevention and cancer treatment
Kalyanaraman, B., Cheng, G., & Hardy, M. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110172 · Cited by 34
“Cancer cells alter the metabolic pathway for survival, growth, and progression through metabolic reprogramming [22,23].”
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
Gremke, N., Besong, I., Stroh, A., von Wichert, L., Witt, M., Elmshäuser, S., Wanzel, M., Fromm, M. F., Taudte, R. V., Schmatloch, S., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02180-4 · Cited by 36
“33 These processes can be pharmacologically targeted with inhibitors of pyruvate dehydrogenase kinase, for example, dichloroacetate (DCA), promoting entry of the glycolytic end product pyruvate into the TCA cycle, or with biguanides like Metformin, which inhibit the mitochondrial ETC. 34 While…”
Wang, Y., Dong, Z.-K., & Jin, W. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02396-6 · Cited by 34
“Tumor cells adapt to hypoxic and nutrient-deprived microenvironments by reprogramming metabolic pathways (e.g., glycolysis, glutaminolysis), while influencing immune cell and stromal cell functions through the release of metabolites such as lactate and ketone bodies [95–99].”
Yue, L., Wang, S., & Willner, I. (2019) · Science Advances · doi:10.1126/sciadv.aav5564 · Cited by 28
“C TGCTCAGCGATGTTCTTC TTGCAACTGAATrAGGAACAGATATACA GAACATCG-3′; (38) H2, 5′-GGTGGTTCTAAATAATCAGGATrAGGAGGACAGCAAGAAGAA CCACCCATGTTACTCT-3′; (39) H3, 5′-GAGGGATAGTGACTTCAAGCTAATrAGG AACAGACATCACACTATCCC-3′; (40) H4, 5′-CCCTTAGTGTTAATATCAGGATrA GGAATGGAGAAGTCACTAAGGGAGGGAGG-3′; (41) H5, 5′-AAATGACGTAAAT AAGCTAATrAGGAGGAC…”
BackgroundCell type-dependent effects of ellagic acid on cellular metabolism
Boehning, A. L., Essien, S. A., Underwood, E. L., Dash, P. K., & Boehning, D. F. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.142 · Cited by 29
Metabolic and Amino Acid Alterations of the Tumor Microenvironment
Štěpka, P., Všianský, V., Raudenská, M., Gumulec, J., Adam, V., & Masařík, M. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200207114658 · Cited by 32
Metformin: (future) best friend of the radiation oncologist?
Chevalier, B., Pasquier, D., Lartigau, E. F., Chargari, C., Schernberg, A., Jannin, A., Mirabel, X., Vantyghem, M., & Escande, A. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.06.030 · Cited by 28
Chu, Y., Zhang, W., Kanimozhi, G., R, B. G., & Tian, D. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8886955 · Cited by 32
“Several studies have demonstrated that cancer cells have a unique metabolism and oxidative environment when compared to normal cells [6].”
BackgroundMicrofluidic Tumor-on-a-Chip Model to Study Tumor Metabolic Vulnerability
Ayuso, J. M., Rehman, S., Farooqui, M. A., Virumbrales-Muñoz, M., Setaluri, V., Skala, M. C., & Beebe, D. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239075 · Cited by 28
“, ATP synthetase inhibitor), have also been explored as potential cancer therapeutics [3].”
BackgroundSuccinate Anaplerosis Has an Onco-Driving Potential in Prostate Cancer Cells
Silva, A. C. B. S., Pérez-Valencia, J. A., Sciacovelli, M., Lalou, C., Sarlak, S., Tronci, L., Nikitopoulou, E., Mészáros, A., Frezza, C., Rossignol, R., et al. (2021) · Cancers · doi:10.3390/cancers13071727 · Cited by 29
“However, many studies have shown that mitochondrial function is essential for tumor growth [5], and changes in expression of glucose transporters and glycolytic enzymes are more associated with proliferating cells rather than solely malignant transformation [1].”
BackgroundNagineni, C. N., Naz, S., Choudhuri, R., Chandramouli, G. V. R., Krishna, M. C., Brender, J., Cook, J. A., & Mitchell, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094835 · Cited by 29
“Lactate is considered as a key player in aerobic glycolysis and tumor metabolism by balancing glycolysis and the TCA cycle [33,34,57,58].”
BackgroundInfluentialBi, G., Bian, Y., Liang, J., Yin, J., Li, R., Zhao, M., Huang, Y., Lu, T., Zhan, C., Fan, H. X., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02889-0 · Cited by 31
“Metabolism associated somatic genomic changes The reprogramming of the glycolytic and OHPHOS status can be largely viewed as a consequence of oncogenic driver events [42].”
BackgroundResultCell mechanical properties of human breast carcinoma cells depend on temperature
Aermes, C., Hayn, A., Fischer, T., & Mierke, C. T. (2021) · Scientific Reports · doi:10.1038/s41598-021-90173-y · Cited by 27
Metadata
- Authors
- DeBerardinis, R. J., & Chandel, N. S.
- Affiliations
- Children's Medical Center (US)
- Northwestern University (US)
- Corresponding author
- DeBerardinis, Ralph J.
- Chandel, Navdeep S.
- Venue
- Science Advances
- Published
- 2016-05-06
- Volume
- 2
- Issue
- 5
- Pages
- e1600200-e1600200
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC4928883
- OpenAlex
- W2395626624
- Semantic Scholar
- bebecd5b21653ab07940aa17ec319c54e710f9dc
- Cited by
- 3,013
- References
- 204
- Citations by year
- 2026: 271 · 2025: 296 · 2024: 326 · 2023: 359 · 2022: 427 · 2021: 447 · 2020: 340 · 2019: 257 · 2018: 166 · 2017: 109 · 2016: 12
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (ID0E1EAG7327, R01 CA123067)
- National Cancer Institute (ID0EAMAG7328, 5R01CA157996)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, metabolic reprogramming, tumor bioenergetics, redox metabolism, nutrient acquisition, carcinogenesis, metastasis, cancer therapy
- MeSH terms
- Animals, Energy Metabolism, Humans, Mitochondria, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Macromolecular Substances, Metabolic Networks and Pathways, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.